Where can I find the actual sales figures?

The specific preliminary sales figures and any related commentary are contained within the press release that is attached as Exhibit 99.1 to this 8-K filing.

When will Boston Scientific release its full, audited financial results?

This 8-K filing only provides preliminary sales results. Investors should look for Boston Scientific's official earnings release and subsequent 10-Q or 10-K filing for the complete, audited financial statements and detailed management discussion.

Does this filing include any forward-looking statements or guidance?

While the press release (Exhibit 99.1) might contain forward-looking statements as is customary, this 8-K filing itself primarily serves to report the preliminary sales results. Detailed guidance would typically be provided in the full earnings release or investor calls.

BSX 8-K: Earnings & Results

Q: What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly announce Boston Scientific's preliminary, unaudited sales results for the fourth quarter and full year ended December 31, 2018, through an attached press release.

Summary

Boston Scientific Corporation (BSX) has filed an 8-K report on January 8, 2019, to announce preliminary, unaudited sales results for the fourth quarter and the full year ended December 31, 2018. The filing primarily serves to furnish the press release containing these results, which is attached as Exhibit 99.1. This provides investors with an early look at the company's top-line performance ahead of its official earnings release.

Key Highlights

1Preliminary unaudited sales results for Q4 and full-year 2018 are being disclosed.
2The disclosure is made via a press release attached as Exhibit 99.1 to the 8-K filing.
3The event date for the results announcement was January 7, 2019.
4This filing is informational, providing early sales figures without detailed financial statements.
5Investors should refer to the attached press release for specific sales figures and commentary.
6The information is furnished and not deemed 'filed' for certain SEC liability purposes.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Jan 8, 2019)

Summary

Key Highlights

Frequently Asked Questions